SCHROEDER THILO sold 4.1% of their position (77.69K shares) of PMV PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.81M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−26.87K
Price / share
$36.38
Trade value
$977.57K
% of position
Common Stock
Shares
−8.74K
Price / share
$36.70
Trade value
$320.76K
% of position
Common Stock
Shares
−19.70K
Price / share
$36.61
Trade value
$721.22K
% of position
Common Stock
Shares
−200.00
Price / share
$36.94
Trade value
$7.39K
% of position
Common Stock
Shares
−13.26K
Price / share
$35.14
Trade value
$465.92K
% of position
Common Stock
Shares
−8.62K
Price / share
$36.08
Trade value
$311.12K
% of position
Common Stock
Shares
−300.00
Price / share
$36.64
Trade value
$10.99K
% of position
Net shares
−77.69K
Net value
-$2.81M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/5/2021 | S · Sale | −26.87K | $36.38 | $977.57K | 1.4% | 1.90M | 1.87M |
| Common Stock Indirect | 8/5/2021 | S · Sale | −8.74K | $36.70 | $320.76K | 0.5% | 1.87M | 1.86M |
| Common Stock Indirect | 8/6/2021 | S · Sale | −19.70K | $36.61 | $721.22K | 1.1% | 1.86M | 1.84M |
| Common Stock Indirect | 8/6/2021 | S · Sale | −200.00 | $36.94 | $7.39K | 0.0% | 1.84M | 1.84M |
| Common Stock Indirect | 8/9/2021 | S · Sale | −13.26K | $35.14 | $465.92K | 0.7% | 1.84M | 1.83M |
| Common Stock Indirect | 8/9/2021 | S · Sale | −8.62K | $36.08 | $311.12K | 0.5% | 1.83M | 1.82M |
| Common Stock Indirect | 8/9/2021 | S · Sale | −300.00 | $36.64 | $10.99K | 0.0% | 1.82M | 1.82M |
| Total | −77.69K | -$2.81M | ||||||